EDNRA and isolated hemihyperplasia: In the present study, we investigated whether pharmacological inhibition of ET-1 signaling with the selective ETA or ETB receptor antagonists, BQ-123 or BQ-788, respectively, would ameliorate the detrimental impact of IH on glucose homeostasis.